Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH210]LH-RH ethylamide

article OA: closed CC0 ⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-08

This study investigated hormonal and biochemical alterations in women with endometriosis undergoing treatment with the LH-RH agonist [D-Trp6, des-Gly-NH210]LH-RH ethylamide.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adrenal Cortex Hormones Endometriosis Gonadal Steroid Hormones Gonadotropin-Releasing Hormone Triptorelin Pamoate Triptorelin Pamoate Adrenal Cortex Hormones Adult Endometriosis Endometriosis Endometriosis Female Gonadal Steroid Hormones Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Osmolar Concentration

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (27)

Cited by (9)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:10.587122+00:00
License: CC0 · commercial use OK